ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $7,977,000 | +53.6% | 85,834 | -1.6% | 0.01% | +42.9% |
Q3 2021 | $5,193,000 | -10.4% | 87,208 | +2.6% | 0.01% | -12.5% |
Q2 2021 | $5,798,000 | -6.8% | 85,009 | -5.2% | 0.01% | 0.0% |
Q1 2021 | $6,224,000 | -20.1% | 89,698 | -11.5% | 0.01% | -27.3% |
Q4 2020 | $7,786,000 | +14.8% | 101,341 | +11.8% | 0.01% | 0.0% |
Q3 2020 | $6,780,000 | -1.3% | 90,650 | -16.9% | 0.01% | 0.0% |
Q2 2020 | $6,870,000 | +113.9% | 109,141 | +42.7% | 0.01% | +57.1% |
Q1 2020 | $3,212,000 | -5.7% | 76,488 | +2.0% | 0.01% | +16.7% |
Q4 2019 | $3,407,000 | +3.6% | 75,015 | +4.4% | 0.01% | 0.0% |
Q3 2019 | $3,289,000 | -20.3% | 71,867 | +2.1% | 0.01% | -25.0% |
Q2 2019 | $4,127,000 | +37.5% | 70,399 | +5.1% | 0.01% | +33.3% |
Q1 2019 | $3,002,000 | +14.2% | 66,965 | -0.8% | 0.01% | 0.0% |
Q4 2018 | $2,629,000 | +23.4% | 67,489 | +45.8% | 0.01% | +50.0% |
Q3 2018 | $2,130,000 | +0.6% | 46,286 | -4.7% | 0.00% | 0.0% |
Q2 2018 | $2,118,000 | +42.2% | 48,581 | +28.9% | 0.00% | +33.3% |
Q1 2018 | $1,489,000 | +22.1% | 37,698 | +5.0% | 0.00% | +50.0% |
Q4 2017 | $1,219,000 | +17.2% | 35,888 | -12.0% | 0.00% | 0.0% |
Q3 2017 | $1,040,000 | +70.8% | 40,771 | +12.9% | 0.00% | +100.0% |
Q2 2017 | $609,000 | – | 36,114 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |